HOLLY WAHAB: Open Payments
NPI 1316155013 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 23 payments from 8 companies in 2025. Trend: 2023 $998 · 2024 $1,104 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $224 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $68 |
| Alexion Pharmaceuticals, Inc. | 2 | $62 |
| PFIZER INC. | 3 | $57 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: TEFLARO, DALVANCE, JARDIANCE, XIFAXAN, ULTOMIRIS, ELIQUIS, UBRELVY, GIVLAARI.
Industry payments across NC — which companies pay providers there.
